Use of gene expression signature technology to identify VVP-808, a novel insulin sensitiser with efficacy in vitro and in vivo

Walder, K. R., Molero, J. C., Konstantopoulos, N., Segal, D., Foletta, V., Windmill, K., Curran, J., Dyer, T., Shields, K., Jowett, J., Krippner, G., Blangero, J. and Collier, G. 2008, Use of gene expression signature technology to identify VVP-808, a novel insulin sensitiser with efficacy in vitro and in vivo, Diabetologia : clinical and experimental diabetes and metabolism, vol. 51, no. Supplement 1, pp. S374-S375.

Attached Files
Name Description MIMEType Size Downloads

Title Use of gene expression signature technology to identify VVP-808, a novel insulin sensitiser with efficacy in vitro and in vivo
Author(s) Walder, K. R.
Molero, J. C.
Konstantopoulos, N.
Segal, D.
Foletta, V.
Windmill, K.
Curran, J.
Dyer, T.
Shields, K.
Jowett, J.
Krippner, G.
Blangero, J.
Collier, G.
Journal name Diabetologia : clinical and experimental diabetes and metabolism
Volume number 51
Issue number Supplement 1
Start page S374
End page S375
Publisher Springer
Place of publication Berlin, Germany
Publication date 2008
ISSN 0012-186X
1432-0428
Notes This article is located on the 374th page in the attached link.
Language eng
Field of Research 110306 Endocrinology
100402 Medical Biotechnology Diagnostics (incl Biosensors)
HERDC Research category C2.1 Other contribution to refereed journal
Copyright notice ©2008, Springer
Persistent URL http://hdl.handle.net/10536/DRO/DU:30022136

Connect to link resolver
 
Unless expressly stated otherwise, the copyright for items in DRO is owned by the author, with all rights reserved.

Versions
Version Filter Type
Access Statistics: 409 Abstract Views, 7 File Downloads  -  Detailed Statistics
Created: Mon, 18 Jan 2010, 11:05:08 EST

Every reasonable effort has been made to ensure that permission has been obtained for items included in DRO. If you believe that your rights have been infringed by this repository, please contact drosupport@deakin.edu.au.